Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in AmerisourceBergen Corp. (NYSE:ABC) by 14.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,468 shares of the company’s stock after purchasing an additional 4,066 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in AmerisourceBergen were worth $2,644,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. LS Investment Advisors LLC grew its stake in AmerisourceBergen by 6.7% in the third quarter. LS Investment Advisors LLC now owns 12,856 shares of the company’s stock worth $1,058,000 after purchasing an additional 811 shares during the period. Voya Investment Management LLC grew its stake in shares of AmerisourceBergen by 24.0% in the third quarter. Voya Investment Management LLC now owns 290,573 shares of the company’s stock worth $23,923,000 after acquiring an additional 56,272 shares during the last quarter. Endurant Capital Management LP grew its stake in shares of AmerisourceBergen by 43.5% in the third quarter. Endurant Capital Management LP now owns 105,501 shares of the company’s stock worth $8,686,000 after acquiring an additional 31,998 shares during the last quarter. Resources Management Corp CT ADV purchased a new stake in shares of AmerisourceBergen in the third quarter worth $73,000. Finally, Usca Ria LLC grew its stake in shares of AmerisourceBergen by 0.5% in the third quarter. Usca Ria LLC now owns 33,580 shares of the company’s stock worth $2,765,000 after acquiring an additional 171 shares during the last quarter. 66.80% of the stock is currently owned by institutional investors.
NYSE ABC opened at $94.36 on Friday. AmerisourceBergen Corp. has a 12 month low of $70.55 and a 12 month high of $97.50. The stock has a market cap of $19.46 billion, a P/E ratio of 30.54, a P/E/G ratio of 1.66 and a beta of 1.01. The stock’s fifty day moving average price is $88.42 and its 200-day moving average price is $86.41. The company has a current ratio of 0.95, a quick ratio of 0.56 and a debt-to-equity ratio of 1.18.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 14th will be given a dividend of $0.42 per share. The ex-dividend date is Thursday, February 13th. This is a boost from AmerisourceBergen’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 1.78%. AmerisourceBergen’s dividend payout ratio (DPR) is 23.70%.
In related news, CEO Steven H. Collis sold 19,905 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $84.42, for a total transaction of $1,680,380.10. Following the sale, the chief executive officer now directly owns 162,027 shares of the company’s stock, valued at $13,678,319.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Gina Clark sold 10,917 shares of the stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $88.24, for a total value of $963,316.08. Insiders have sold 64,417 shares of company stock worth $5,743,456 over the last ninety days. 28.30% of the stock is currently owned by insiders.
A number of equities research analysts have recently commented on the company. Robert W. Baird raised AmerisourceBergen from a “neutral” rating to an “outperform” rating and set a $112.00 target price on the stock in a research note on Friday, February 7th. Argus reissued a “buy” rating and issued a $110.00 target price on shares of AmerisourceBergen in a research note on Monday, November 18th. ValuEngine cut AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. TheStreet raised AmerisourceBergen from a “c+” rating to a “b-” rating in a research note on Friday, December 6th. Finally, Credit Suisse Group reissued a “buy” rating and issued a $98.00 target price on shares of AmerisourceBergen in a research note on Sunday, February 2nd. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $95.13.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Featured Article: Hedge Funds Explained
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.